Ajanta Pharma Limited (AJANTPHARM.NS)
Company Info
Highlights
₹323.10B
₹73.58
35.15
₹46.48B
₹32.60B
₹10.12B
₹2,092.05 - ₹3,453.64
₹3,020.17
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of ₹10,000 in Ajanta Pharma Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Ajanta Pharma Limited (AJANTPHARM.NS) returned -14.09% year-to-date (YTD) and 7.36% over the past 12 months. Over the past 10 years, AJANTPHARM.NS delivered an annualized return of 12.67%, outperforming the S&P 500 benchmark at 10.43%.
AJANTPHARM.NS
-14.09%
0.98%
-15.63%
7.36%
22.55%
12.67%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of AJANTPHARM.NS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -8.11% | -7.74% | 5.51% | 3.17% | -6.91% | -14.09% | |||||||
| 2024 | 4.35% | 2.74% | 1.03% | -0.69% | 5.31% | -1.97% | 17.83% | 20.35% | -1.29% | -4.28% | -0.48% | -2.99% | 43.66% |
| 2023 | -0.18% | -2.28% | 2.25% | 8.59% | -0.33% | 13.06% | 14.74% | 2.67% | 4.20% | -2.04% | 12.08% | 5.44% | 73.44% |
| 2022 | -1.55% | -21.75% | 5.15% | -4.95% | -0.47% | 8.20% | 3.48% | 7.14% | -7.12% | 1.77% | -4.60% | -1.35% | -18.22% |
| 2021 | 8.13% | -1.04% | 2.53% | 2.69% | 4.38% | 11.87% | 6.67% | -2.81% | 2.26% | -6.96% | -1.43% | 7.47% | 37.48% |
| 2020 | 13.73% | 24.97% | -1.36% | 8.85% | 2.47% | -7.01% | 14.96% | -8.88% | 8.69% | -2.51% | -1.75% | 6.32% | 68.63% |
| 2019 | -13.92% | -4.09% | 4.75% | -3.41% | 5.57% | -8.58% | -7.74% | 15.98% | -1.19% | 3.97% | -3.84% | -2.24% | -16.70% |
| 2018 | -2.68% | -3.71% | -0.53% | -2.52% | -28.99% | 2.11% | 15.82% | 11.65% | -16.29% | -0.51% | 11.34% | 1.47% | -19.83% |
| 2017 | -4.41% | 0.77% | 2.90% | -6.15% | -4.99% | -1.59% | -9.56% | -14.54% | -4.95% | 7.51% | 12.30% | 8.86% | -16.02% |
| 2016 | -4.34% | 2.21% | 8.85% | 7.48% | 0.28% | -1.09% | 18.61% | 6.72% | 5.57% | 1.72% | -6.76% | -6.05% | 35.08% |
| 2015 | 9.78% | 6.71% | 12.70% | 2.77% | 25.07% | -0.29% | -0.33% | -4.10% | -1.34% | 4.71% | -14.42% | 0.43% | 43.62% |
| 2014 | -0.29% | 10.25% | -4.39% | -0.26% | 8.28% | 52.82% | -1.10% | -1.49% | 8.90% | 9.71% | 24.37% | -1.49% | 147.35% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of AJANTPHARM.NS is 57, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Ajanta Pharma Limited (AJANTPHARM.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Ajanta Pharma Limited provided a 1.11% dividend yield over the last twelve months, with an annual payout of ₹28.00 per share. The company has been increasing its dividends for 4 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₹28.00 | ₹54.00 | ₹10.00 | ₹7.00 | ₹6.33 | ₹6.33 | ₹8.67 | ₹6.00 | ₹4.67 | ₹9.33 | ₹4.00 | ₹2.67 |
Dividend yield | 1.11% | 1.84% | 0.48% | 0.58% | 0.42% | 0.58% | 1.33% | 0.76% | 0.47% | 0.79% | 0.45% | 0.43% |
Monthly Dividends
The table displays the monthly dividend distributions for Ajanta Pharma Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | |||||||
| 2024 | ₹0.00 | ₹26.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹28.00 | ₹0.00 | ₹54.00 |
| 2023 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹10.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹10.00 |
| 2022 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹7.00 | ₹0.00 | ₹7.00 |
| 2021 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.33 | ₹0.00 | ₹6.33 |
| 2020 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.33 | ₹0.00 | ₹6.33 |
| 2019 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹8.67 | ₹0.00 | ₹8.67 |
| 2018 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.00 | ₹0.00 | ₹6.00 |
| 2017 | ₹0.00 | ₹0.00 | ₹4.67 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.67 |
| 2016 | ₹0.00 | ₹0.00 | ₹5.33 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹9.33 |
| 2015 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 |
| 2014 | ₹2.67 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹2.67 |
Dividend Yield & Payout
Dividend Yield
Ajanta Pharma Limited has a dividend yield of 1.11%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Ajanta Pharma Limited has a payout ratio of 38.16%, which is quite average when compared to the overall market. This suggests that Ajanta Pharma Limited strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Ajanta Pharma Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ajanta Pharma Limited was 61.73%, occurring on Oct 27, 2008. Recovery took 298 trading sessions.
The current Ajanta Pharma Limited drawdown is 25.81%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.73% | Jul 29, 2005 | 804 | Oct 27, 2008 | 298 | Jan 20, 2010 | 1102 |
| -59% | Jul 10, 2002 | 189 | Mar 31, 2003 | 109 | Aug 29, 2003 | 298 |
| -57.27% | Oct 4, 2016 | 696 | Jul 30, 2019 | 473 | Jun 29, 2021 | 1169 |
| -53.79% | Sep 9, 2003 | 141 | Mar 23, 2004 | 197 | Dec 23, 2004 | 338 |
| -36.62% | Jul 19, 2013 | 28 | Aug 29, 2013 | 39 | Oct 28, 2013 | 67 |
Volatility
Volatility Chart
The current Ajanta Pharma Limited volatility is 13.71%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Ajanta Pharma Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Ajanta Pharma Limited, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 6.5% positive surprise.
Valuation
The Valuation section provides an overview of how Ajanta Pharma Limited is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for AJANTPHARM.NS, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, AJANTPHARM.NS has a P/E ratio of 35.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AJANTPHARM.NS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, AJANTPHARM.NS has a P/S ratio of 7.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AJANTPHARM.NS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, AJANTPHARM.NS has a P/B value of 8.5. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |